Ring Relief
Active substance: ARNICA MONTANA, CALCIUM SULFIDE, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM SPORE, MERCURIUS SOLUBILIS, SALICYLIC ACID, SILICON DIOXIDE, ALLYLTHIOUREA
TABLET, ORALLY DISINTEGRATING · ARNICA MONTANA 6 [hp_X]/1, CALCIUM SULFIDE 13 [hp_X]/1, HYPERICUM PERFORATUM 6 [hp_X]/1, LYCOPODIUM CLAVATUM SPORE 12 [hp_X]/1, MERCURIUS SOLUBILIS 13 [hp_X]/1, SALICYLIC ACID 6 [hp_X]/1, SILICON DIOXIDE 13 [hp_X]/1, ALLYLTHIOUREA 6 [hp_X]/1
United StatesActive
Marketing holder: TRP Company
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ARNICA MONTANA · 6 [hp_X]/1
- CALCIUM SULFIDE · 13 [hp_X]/1
- HYPERICUM PERFORATUM · 6 [hp_X]/1
- LYCOPODIUM CLAVATUM SPORE · 12 [hp_X]/1
- MERCURIUS SOLUBILIS · 13 [hp_X]/1
- SALICYLIC ACID · 6 [hp_X]/1
- SILICON DIOXIDE · 13 [hp_X]/1
- ALLYLTHIOUREA · 6 [hp_X]/1
Registration
- Registration number
- 17312-023
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- ORAL
Sources
- product · openFDA NDC · 17312-023 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 17312-023 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 17312-023 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 17312-023 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 17312-023 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 17312-023 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 17312-023 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 17312-023 · Verified 2026-10-09 · open in source
- ingredients.6 · openFDA NDC · 17312-023 · Verified 2026-10-09 · open in source
- ingredients.7 · openFDA NDC · 17312-023 · Verified 2026-10-09 · open in source